E. Daniel Et Al. , "Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry," 10th International Meeting Of Pediatric Endocrinology , Washington, United States Of America, 2017
Daniel, E. Et Al. 2017. Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry. 10th International Meeting Of Pediatric Endocrinology , (Washington, United States Of America).
Daniel, E., Sandrk, M., Blankenstein, O., Neumann, U., Grinten, H., Linde, A., ... Darendeliler, F. F.(2017). Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry . 10th International Meeting Of Pediatric Endocrinology, Washington, United States Of America
Daniel, E Et Al. "Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry," 10th International Meeting Of Pediatric Endocrinology, Washington, United States Of America, 2017
Daniel, E Et Al. "Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry." 10th International Meeting Of Pediatric Endocrinology , Washington, United States Of America, 2017
Daniel, E. Et Al. (2017) . "Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry." 10th International Meeting Of Pediatric Endocrinology , Washington, United States Of America.
@conferencepaper{conferencepaper, author={E Daniel Et Al. }, title={Defining the dose, type and timing of glucocorticoid and mineralocorticoid replacement in 256 children and adults with CAH in the I-CAH registry}, congress name={10th International Meeting Of Pediatric Endocrinology}, city={Washington}, country={United States Of America}, year={2017}}